nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Ethinamate—CA2—kidney cancer	0.021	1	CrCbGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—FOSL1—kidney cancer	0.0038	0.0532	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—RYR1—kidney cancer	0.00378	0.0529	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—CCBL1—kidney cancer	0.003	0.042	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—HSPD1—kidney cancer	0.00293	0.041	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNA1—kidney cancer	0.00275	0.0385	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GJB1—kidney cancer	0.00251	0.0351	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—SLC2A1—kidney cancer	0.00201	0.0281	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—ITPR2—kidney cancer	0.00164	0.023	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNA1—kidney cancer	0.00154	0.0215	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ITPR2—kidney cancer	0.00146	0.0204	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—BIRC5—kidney cancer	0.0014	0.0196	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—ITPR2—kidney cancer	0.00129	0.018	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—SLC2A1—kidney cancer	0.00124	0.0174	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—PSMD7—kidney cancer	0.00111	0.0155	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—KCNMA1—kidney cancer	0.00109	0.0153	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—ACHE—kidney cancer	0.00105	0.0147	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—SLC5A5—kidney cancer	0.00104	0.0146	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—SLC2A1—kidney cancer	0.000978	0.0137	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000917	0.0128	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—kidney cancer	0.00089	0.0125	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—ACHE—kidney cancer	0.000806	0.0113	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—KCNMA1—kidney cancer	0.000722	0.0101	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—BCHE—kidney cancer	0.000702	0.00983	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000697	0.00976	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ACY1—kidney cancer	0.00069	0.00965	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—HNF1B—kidney cancer	0.000684	0.00957	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—KCNMA1—kidney cancer	0.000666	0.00932	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—kidney cancer	0.00063	0.00881	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000607	0.0085	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—JUND—kidney cancer	0.000598	0.00836	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PDHB—kidney cancer	0.000586	0.0082	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CCBL1—kidney cancer	0.000551	0.00771	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—ACHE—kidney cancer	0.000534	0.00747	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—kidney cancer	0.000517	0.00724	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—kidney cancer	0.000496	0.00694	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPAT—kidney cancer	0.000478	0.00669	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GLIPR1—kidney cancer	0.000478	0.00669	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000468	0.00655	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BCHE—kidney cancer	0.000465	0.00651	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—OR4C13—kidney cancer	0.000462	0.00647	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—FH—kidney cancer	0.000444	0.00622	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APRT—kidney cancer	0.000444	0.00622	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—OR4C13—kidney cancer	0.00042	0.00587	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ACY1—kidney cancer	0.000418	0.00585	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPC3—kidney cancer	0.000418	0.00585	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CA2—kidney cancer	0.000406	0.00569	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—ANXA1—kidney cancer	0.0004	0.00559	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALAD—kidney cancer	0.000396	0.00554	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000391	0.00547	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ST3GAL2—kidney cancer	0.000387	0.00541	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—EGR1—kidney cancer	0.00038	0.00532	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALDH1A1—kidney cancer	0.000378	0.00529	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PGK1—kidney cancer	0.000362	0.00507	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC5A3—kidney cancer	0.000362	0.00507	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—BRAF—kidney cancer	0.000358	0.00502	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PDHB—kidney cancer	0.000355	0.00497	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LDHB—kidney cancer	0.000355	0.00497	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CCBL1—kidney cancer	0.000334	0.00467	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000318	0.00445	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.00031	0.00434	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CA9—kidney cancer	0.000308	0.00431	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—RAF1—kidney cancer	0.000299	0.00419	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPAT—kidney cancer	0.00029	0.00405	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GLIPR1—kidney cancer	0.00029	0.00405	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APRT—kidney cancer	0.000269	0.00377	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FH—kidney cancer	0.000269	0.00377	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000268	0.00375	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CRABP1—kidney cancer	0.000262	0.00366	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000259	0.00362	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPC3—kidney cancer	0.000253	0.00354	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—OR4C13—kidney cancer	0.000248	0.00347	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CA2—kidney cancer	0.000246	0.00345	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ITPR2—kidney cancer	0.000243	0.00341	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ANXA1—kidney cancer	0.000242	0.00339	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALAD—kidney cancer	0.00024	0.00336	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BRAF—kidney cancer	0.000237	0.00332	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ST3GAL2—kidney cancer	0.000234	0.00328	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALDH1A1—kidney cancer	0.000229	0.0032	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ACHE—kidney cancer	0.000222	0.00311	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTT1—kidney cancer	0.000222	0.00311	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PGK1—kidney cancer	0.000219	0.00307	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC5A3—kidney cancer	0.000219	0.00307	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LDHB—kidney cancer	0.000215	0.00301	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LATS1—kidney cancer	0.000211	0.00295	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SCARB1—kidney cancer	0.00021	0.00294	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS1—kidney cancer	0.000208	0.00291	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—MAPK1—kidney cancer	0.000205	0.00287	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PSMD7—kidney cancer	0.000204	0.00285	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—RAF1—kidney cancer	0.000198	0.00277	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—POMC—kidney cancer	0.000196	0.00274	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—BCHE—kidney cancer	0.000193	0.00271	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKAP13—kidney cancer	0.000192	0.00269	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC5A5—kidney cancer	0.000191	0.00267	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CA9—kidney cancer	0.000187	0.00261	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC2A1—kidney cancer	0.000185	0.00258	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AMER1—kidney cancer	0.000179	0.00251	CbGpPWpGaD
Gabapentin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000179	0.000197	CcSEcCtD
Gabapentin—Infection—Paclitaxel—kidney cancer	0.000179	0.000197	CcSEcCtD
Gabapentin—Flatulence—Capecitabine—kidney cancer	0.000178	0.000196	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000177	0.00248	CbGpPWpGaD
Gabapentin—Dry skin—Doxorubicin—kidney cancer	0.000177	0.000196	CcSEcCtD
Gabapentin—Dysgeusia—Capecitabine—kidney cancer	0.000177	0.000195	CcSEcCtD
Gabapentin—Dizziness—Sunitinib—kidney cancer	0.000177	0.000195	CcSEcCtD
Gabapentin—Feeling abnormal—Gemcitabine—kidney cancer	0.000177	0.000195	CcSEcCtD
Gabapentin—Shock—Paclitaxel—kidney cancer	0.000177	0.000195	CcSEcCtD
Gabapentin—Vomiting—Sorafenib—kidney cancer	0.000177	0.000195	CcSEcCtD
Gabapentin—Nervous system disorder—Paclitaxel—kidney cancer	0.000176	0.000194	CcSEcCtD
Gabapentin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000176	0.000194	CcSEcCtD
Gabapentin—Tachycardia—Paclitaxel—kidney cancer	0.000176	0.000193	CcSEcCtD
Gabapentin—Rash—Sorafenib—kidney cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Dermatitis—Sorafenib—kidney cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Back pain—Capecitabine—kidney cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Breast disorder—Doxorubicin—kidney cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Skin disorder—Paclitaxel—kidney cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Headache—Sorafenib—kidney cancer	0.000174	0.000192	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AKAP13—kidney cancer	0.000174	0.00244	CbGpPWpGaD
Gabapentin—Muscle spasms—Capecitabine—kidney cancer	0.000174	0.000192	CcSEcCtD
Gabapentin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000174	0.000192	CcSEcCtD
Gabapentin—Diarrhoea—Dactinomycin—kidney cancer	0.000173	0.000191	CcSEcCtD
Gabapentin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000173	0.000191	CcSEcCtD
Gabapentin—Anorexia—Paclitaxel—kidney cancer	0.000171	0.000189	CcSEcCtD
Gabapentin—Gastritis—Doxorubicin—kidney cancer	0.000171	0.000189	CcSEcCtD
Gabapentin—Muscular weakness—Doxorubicin—kidney cancer	0.000171	0.000188	CcSEcCtD
Gabapentin—Vision blurred—Capecitabine—kidney cancer	0.00017	0.000188	CcSEcCtD
Gabapentin—Vomiting—Sunitinib—kidney cancer	0.00017	0.000188	CcSEcCtD
Gabapentin—Body temperature increased—Gemcitabine—kidney cancer	0.00017	0.000187	CcSEcCtD
Gabapentin—Tremor—Capecitabine—kidney cancer	0.000169	0.000187	CcSEcCtD
Gabapentin—Rash—Sunitinib—kidney cancer	0.000169	0.000186	CcSEcCtD
Gabapentin—Dermatitis—Sunitinib—kidney cancer	0.000169	0.000186	CcSEcCtD
Gabapentin—Hypotension—Paclitaxel—kidney cancer	0.000168	0.000185	CcSEcCtD
Gabapentin—Ill-defined disorder—Capecitabine—kidney cancer	0.000168	0.000185	CcSEcCtD
Gabapentin—Headache—Sunitinib—kidney cancer	0.000168	0.000185	CcSEcCtD
Gabapentin—Influenza—Doxorubicin—kidney cancer	0.000167	0.000184	CcSEcCtD
Gabapentin—Dysphagia—Doxorubicin—kidney cancer	0.000167	0.000184	CcSEcCtD
Gabapentin—Asthma—Doxorubicin—kidney cancer	0.000167	0.000184	CcSEcCtD
Gabapentin—Anaemia—Capecitabine—kidney cancer	0.000167	0.000184	CcSEcCtD
Gabapentin—Hypersensitivity—Vincristine—kidney cancer	0.000167	0.000184	CcSEcCtD
Gabapentin—Eosinophilia—Doxorubicin—kidney cancer	0.000166	0.000183	CcSEcCtD
Gabapentin—Nausea—Sorafenib—kidney cancer	0.000165	0.000182	CcSEcCtD
Gabapentin—Pancreatitis—Doxorubicin—kidney cancer	0.000164	0.000181	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000164	0.000181	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—ITPR2—kidney cancer	0.000163	0.00228	CbGpPWpGaD
Gabapentin—Malaise—Capecitabine—kidney cancer	0.000163	0.00018	CcSEcCtD
Gabapentin—Angina pectoris—Doxorubicin—kidney cancer	0.000163	0.00018	CcSEcCtD
Gabapentin—Insomnia—Paclitaxel—kidney cancer	0.000163	0.000179	CcSEcCtD
Gabapentin—Vertigo—Capecitabine—kidney cancer	0.000163	0.000179	CcSEcCtD
Gabapentin—Asthenia—Vincristine—kidney cancer	0.000163	0.000179	CcSEcCtD
Gabapentin—Syncope—Capecitabine—kidney cancer	0.000162	0.000179	CcSEcCtD
Gabapentin—Leukopenia—Capecitabine—kidney cancer	0.000162	0.000178	CcSEcCtD
Gabapentin—Paraesthesia—Paclitaxel—kidney cancer	0.000162	0.000178	CcSEcCtD
Gabapentin—Vomiting—Dactinomycin—kidney cancer	0.000161	0.000178	CcSEcCtD
Gabapentin—Bronchitis—Doxorubicin—kidney cancer	0.000161	0.000177	CcSEcCtD
Gabapentin—Dyspnoea—Paclitaxel—kidney cancer	0.00016	0.000177	CcSEcCtD
Gabapentin—Somnolence—Paclitaxel—kidney cancer	0.00016	0.000176	CcSEcCtD
Gabapentin—Palpitations—Capecitabine—kidney cancer	0.00016	0.000176	CcSEcCtD
Gabapentin—Rash—Dactinomycin—kidney cancer	0.00016	0.000176	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—JUN—kidney cancer	0.00016	0.00223	CbGpPWpGaD
Gabapentin—Nausea—Sunitinib—kidney cancer	0.000159	0.000175	CcSEcCtD
Gabapentin—Loss of consciousness—Capecitabine—kidney cancer	0.000159	0.000175	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CRABP1—kidney cancer	0.000159	0.00222	CbGpPWpGaD
Gabapentin—Dyspepsia—Paclitaxel—kidney cancer	0.000158	0.000174	CcSEcCtD
Gabapentin—Cough—Capecitabine—kidney cancer	0.000158	0.000174	CcSEcCtD
Gabapentin—Dysuria—Doxorubicin—kidney cancer	0.000156	0.000172	CcSEcCtD
Gabapentin—Decreased appetite—Paclitaxel—kidney cancer	0.000156	0.000172	CcSEcCtD
Gabapentin—Hypertension—Capecitabine—kidney cancer	0.000156	0.000172	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000156	0.00218	CbGpPWpGaD
Gabapentin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000156	0.000171	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000155	0.000171	CcSEcCtD
Gabapentin—Fatigue—Paclitaxel—kidney cancer	0.000155	0.000171	CcSEcCtD
Gabapentin—Diarrhoea—Vincristine—kidney cancer	0.000155	0.000171	CcSEcCtD
Gabapentin—Pollakiuria—Doxorubicin—kidney cancer	0.000155	0.00017	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—kidney cancer	0.000154	0.00216	CbGpPWpGaD
Gabapentin—Asthenia—Gemcitabine—kidney cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—Arthralgia—Capecitabine—kidney cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—Myalgia—Capecitabine—kidney cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—Chest pain—Capecitabine—kidney cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GSTP1—kidney cancer	0.000154	0.00215	CbGpPWpGaD
Gabapentin—Constipation—Paclitaxel—kidney cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—Pain—Paclitaxel—kidney cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—Anxiety—Capecitabine—kidney cancer	0.000153	0.000169	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000153	0.000169	CcSEcCtD
Gabapentin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000153	0.000168	CcSEcCtD
Gabapentin—Weight increased—Doxorubicin—kidney cancer	0.000152	0.000168	CcSEcCtD
Gabapentin—Discomfort—Capecitabine—kidney cancer	0.000152	0.000168	CcSEcCtD
Gabapentin—Pruritus—Gemcitabine—kidney cancer	0.000152	0.000168	CcSEcCtD
Gabapentin—Weight decreased—Doxorubicin—kidney cancer	0.000151	0.000167	CcSEcCtD
Gabapentin—Hyperglycaemia—Doxorubicin—kidney cancer	0.000151	0.000166	CcSEcCtD
Gabapentin—Dry mouth—Capecitabine—kidney cancer	0.000151	0.000166	CcSEcCtD
Gabapentin—Nausea—Dactinomycin—kidney cancer	0.000151	0.000166	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CER1—kidney cancer	0.00015	0.0021	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GPC3—kidney cancer	0.00015	0.0021	CbGpPWpGaD
Gabapentin—Pneumonia—Doxorubicin—kidney cancer	0.00015	0.000165	CcSEcCtD
Gabapentin—Dizziness—Vincristine—kidney cancer	0.00015	0.000165	CcSEcCtD
Gabapentin—Infestation—Doxorubicin—kidney cancer	0.000149	0.000164	CcSEcCtD
Gabapentin—Drowsiness—Doxorubicin—kidney cancer	0.000149	0.000164	CcSEcCtD
Gabapentin—Infestation NOS—Doxorubicin—kidney cancer	0.000149	0.000164	CcSEcCtD
Gabapentin—Confusional state—Capecitabine—kidney cancer	0.000149	0.000164	CcSEcCtD
Gabapentin—Feeling abnormal—Paclitaxel—kidney cancer	0.000148	0.000163	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—ITPR2—kidney cancer	0.000148	0.00207	CbGpPWpGaD
Gabapentin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000148	0.000163	CcSEcCtD
Gabapentin—Oedema—Capecitabine—kidney cancer	0.000148	0.000163	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ITPR2—kidney cancer	0.000148	0.00206	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000147	0.000162	CcSEcCtD
Gabapentin—Diarrhoea—Gemcitabine—kidney cancer	0.000147	0.000162	CcSEcCtD
Gabapentin—Renal failure—Doxorubicin—kidney cancer	0.000147	0.000162	CcSEcCtD
Gabapentin—Infection—Capecitabine—kidney cancer	0.000147	0.000162	CcSEcCtD
Gabapentin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000146	0.000161	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ABCB1—kidney cancer	0.000146	0.00204	CbGpPWpGaD
Gabapentin—Stomatitis—Doxorubicin—kidney cancer	0.000145	0.00016	CcSEcCtD
Gabapentin—Jaundice—Doxorubicin—kidney cancer	0.000145	0.00016	CcSEcCtD
Gabapentin—Shock—Capecitabine—kidney cancer	0.000145	0.00016	CcSEcCtD
Gabapentin—Urinary tract infection—Doxorubicin—kidney cancer	0.000145	0.00016	CcSEcCtD
Gabapentin—Conjunctivitis—Doxorubicin—kidney cancer	0.000145	0.00016	CcSEcCtD
Gabapentin—Nervous system disorder—Capecitabine—kidney cancer	0.000145	0.00016	CcSEcCtD
Gabapentin—Thrombocytopenia—Capecitabine—kidney cancer	0.000145	0.000159	CcSEcCtD
Gabapentin—Tachycardia—Capecitabine—kidney cancer	0.000144	0.000159	CcSEcCtD
Gabapentin—Vomiting—Vincristine—kidney cancer	0.000144	0.000159	CcSEcCtD
Gabapentin—Skin disorder—Capecitabine—kidney cancer	0.000143	0.000158	CcSEcCtD
Gabapentin—Sweating—Doxorubicin—kidney cancer	0.000143	0.000158	CcSEcCtD
Gabapentin—Urticaria—Paclitaxel—kidney cancer	0.000143	0.000157	CcSEcCtD
Gabapentin—Rash—Vincristine—kidney cancer	0.000143	0.000157	CcSEcCtD
Gabapentin—Hyperhidrosis—Capecitabine—kidney cancer	0.000143	0.000157	CcSEcCtD
Gabapentin—Dermatitis—Vincristine—kidney cancer	0.000143	0.000157	CcSEcCtD
Gabapentin—Haematuria—Doxorubicin—kidney cancer	0.000142	0.000157	CcSEcCtD
Gabapentin—Abdominal pain—Paclitaxel—kidney cancer	0.000142	0.000157	CcSEcCtD
Gabapentin—Body temperature increased—Paclitaxel—kidney cancer	0.000142	0.000157	CcSEcCtD
Gabapentin—Headache—Vincristine—kidney cancer	0.000142	0.000156	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GSTM1—kidney cancer	0.000141	0.00198	CbGpPWpGaD
Gabapentin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000141	0.000155	CcSEcCtD
Gabapentin—Epistaxis—Doxorubicin—kidney cancer	0.000141	0.000155	CcSEcCtD
Gabapentin—Anorexia—Capecitabine—kidney cancer	0.000141	0.000155	CcSEcCtD
Gabapentin—Sinusitis—Doxorubicin—kidney cancer	0.00014	0.000154	CcSEcCtD
Gabapentin—Hypotension—Capecitabine—kidney cancer	0.000138	0.000152	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—ANXA1—kidney cancer	0.000137	0.00191	CbGpPWpGaD
Gabapentin—Vomiting—Gemcitabine—kidney cancer	0.000137	0.000151	CcSEcCtD
Gabapentin—Bradycardia—Doxorubicin—kidney cancer	0.000136	0.00015	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—MAPK1—kidney cancer	0.000136	0.0019	CbGpPWpGaD
Gabapentin—Rash—Gemcitabine—kidney cancer	0.000135	0.000149	CcSEcCtD
Gabapentin—Dermatitis—Gemcitabine—kidney cancer	0.000135	0.000149	CcSEcCtD
Gabapentin—Headache—Gemcitabine—kidney cancer	0.000135	0.000148	CcSEcCtD
Gabapentin—Nausea—Vincristine—kidney cancer	0.000135	0.000148	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ACHE—kidney cancer	0.000135	0.00188	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—kidney cancer	0.000135	0.00188	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000135	0.000148	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—kidney cancer	0.000134	0.000148	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CYP1A1—kidney cancer	0.000134	0.00188	CbGpPWpGaD
Gabapentin—Hepatitis—Doxorubicin—kidney cancer	0.000134	0.000148	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—kidney cancer	0.000134	0.000148	CcSEcCtD
Gabapentin—Insomnia—Capecitabine—kidney cancer	0.000134	0.000147	CcSEcCtD
Gabapentin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000133	0.000147	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—kidney cancer	0.000133	0.000146	CcSEcCtD
Gabapentin—Paraesthesia—Capecitabine—kidney cancer	0.000133	0.000146	CcSEcCtD
Gabapentin—Hypersensitivity—Paclitaxel—kidney cancer	0.000133	0.000146	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000132	0.000146	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—kidney cancer	0.000132	0.000145	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—kidney cancer	0.000132	0.000145	CcSEcCtD
Gabapentin—Dyspnoea—Capecitabine—kidney cancer	0.000132	0.000145	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—kidney cancer	0.000131	0.000145	CcSEcCtD
Gabapentin—Dyspepsia—Capecitabine—kidney cancer	0.00013	0.000143	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—kidney cancer	0.000129	0.000142	CcSEcCtD
Gabapentin—Asthenia—Paclitaxel—kidney cancer	0.000129	0.000142	CcSEcCtD
Gabapentin—Decreased appetite—Capecitabine—kidney cancer	0.000128	0.000141	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SFRP2—kidney cancer	0.000128	0.00179	CbGpPWpGaD
Gabapentin—Nausea—Gemcitabine—kidney cancer	0.000128	0.000141	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000127	0.00014	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SCARB1—kidney cancer	0.000127	0.00178	CbGpPWpGaD
Gabapentin—Fatigue—Capecitabine—kidney cancer	0.000127	0.00014	CcSEcCtD
Gabapentin—Pruritus—Paclitaxel—kidney cancer	0.000127	0.00014	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—kidney cancer	0.000127	0.00014	CcSEcCtD
Gabapentin—Pain—Capecitabine—kidney cancer	0.000126	0.000139	CcSEcCtD
Gabapentin—Constipation—Capecitabine—kidney cancer	0.000126	0.000139	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PTGS1—kidney cancer	0.000126	0.00176	CbGpPWpGaD
Gabapentin—Eye disorder—Doxorubicin—kidney cancer	0.000125	0.000138	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—kidney cancer	0.000125	0.000138	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—kidney cancer	0.000124	0.000137	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—ANXA1—kidney cancer	0.000124	0.00174	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PSMD7—kidney cancer	0.000124	0.00173	CbGpPWpGaD
Gabapentin—Diarrhoea—Paclitaxel—kidney cancer	0.000123	0.000136	CcSEcCtD
Gabapentin—Feeling abnormal—Capecitabine—kidney cancer	0.000122	0.000134	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—kidney cancer	0.000121	0.000133	CcSEcCtD
Gabapentin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000121	0.000133	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—kidney cancer	0.000121	0.000133	CcSEcCtD
Gabapentin—Chills—Doxorubicin—kidney cancer	0.00012	0.000132	CcSEcCtD
Gabapentin—Dizziness—Paclitaxel—kidney cancer	0.000119	0.000131	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—POMC—kidney cancer	0.000119	0.00166	CbGpPWpGaD
Gabapentin—Alopecia—Doxorubicin—kidney cancer	0.000118	0.00013	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—kidney cancer	0.000117	0.000129	CcSEcCtD
Gabapentin—Urticaria—Capecitabine—kidney cancer	0.000117	0.000129	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—BCHE—kidney cancer	0.000117	0.00164	CbGpPWpGaD
Gabapentin—Abdominal pain—Capecitabine—kidney cancer	0.000117	0.000129	CcSEcCtD
Gabapentin—Body temperature increased—Capecitabine—kidney cancer	0.000117	0.000129	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—kidney cancer	0.000117	0.000128	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—kidney cancer	0.000117	0.000128	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SLC5A5—kidney cancer	0.000116	0.00162	CbGpPWpGaD
Gabapentin—Flatulence—Doxorubicin—kidney cancer	0.000115	0.000127	CcSEcCtD
Gabapentin—Tension—Doxorubicin—kidney cancer	0.000114	0.000126	CcSEcCtD
Gabapentin—Vomiting—Paclitaxel—kidney cancer	0.000114	0.000126	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—kidney cancer	0.000114	0.000126	CcSEcCtD
Gabapentin—Rash—Paclitaxel—kidney cancer	0.000113	0.000125	CcSEcCtD
Gabapentin—Dermatitis—Paclitaxel—kidney cancer	0.000113	0.000125	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—kidney cancer	0.000113	0.000125	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—kidney cancer	0.000113	0.000124	CcSEcCtD
Gabapentin—Headache—Paclitaxel—kidney cancer	0.000113	0.000124	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—kidney cancer	0.000112	0.000124	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SLC2A1—kidney cancer	0.000112	0.00156	CbGpPWpGaD
Gabapentin—Vision blurred—Doxorubicin—kidney cancer	0.00011	0.000121	CcSEcCtD
Gabapentin—Hypersensitivity—Capecitabine—kidney cancer	0.000109	0.00012	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000108	0.000119	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—kidney cancer	0.000108	0.000119	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—kidney cancer	0.000107	0.000118	CcSEcCtD
Gabapentin—Nausea—Paclitaxel—kidney cancer	0.000107	0.000118	CcSEcCtD
Gabapentin—Asthenia—Capecitabine—kidney cancer	0.000106	0.000117	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—kidney cancer	0.000105	0.00147	CbGpPWpGaD
Gabapentin—Malaise—Doxorubicin—kidney cancer	0.000105	0.000116	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—kidney cancer	0.000105	0.000115	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—kidney cancer	0.000105	0.000115	CcSEcCtD
Gabapentin—Pruritus—Capecitabine—kidney cancer	0.000104	0.000115	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—kidney cancer	0.000104	0.000115	CcSEcCtD
Gabapentin—Palpitations—Doxorubicin—kidney cancer	0.000103	0.000114	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—AKAP13—kidney cancer	0.000103	0.00144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP2—kidney cancer	0.000103	0.00144	CbGpPWpGaD
Gabapentin—Loss of consciousness—Doxorubicin—kidney cancer	0.000102	0.000113	CcSEcCtD
Gabapentin—Cough—Doxorubicin—kidney cancer	0.000102	0.000112	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—kidney cancer	0.000101	0.000111	CcSEcCtD
Gabapentin—Diarrhoea—Capecitabine—kidney cancer	0.000101	0.000111	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—kidney cancer	0.000101	0.000111	CcSEcCtD
Gabapentin—BCAT1—Metabolism—POMC—kidney cancer	0.0001	0.0014	CbGpPWpGaD
Gabapentin—Myalgia—Doxorubicin—kidney cancer	9.93e-05	0.000109	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—kidney cancer	9.93e-05	0.000109	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—kidney cancer	9.93e-05	0.000109	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—kidney cancer	9.89e-05	0.000109	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.86e-05	0.000109	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—kidney cancer	9.81e-05	0.000108	CcSEcCtD
Gabapentin—Dizziness—Capecitabine—kidney cancer	9.76e-05	0.000108	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—kidney cancer	9.71e-05	0.000107	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—kidney cancer	9.6e-05	0.000106	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—kidney cancer	9.52e-05	0.000105	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—kidney cancer	9.52e-05	0.000105	CcSEcCtD
Gabapentin—Infection—Doxorubicin—kidney cancer	9.45e-05	0.000104	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GRB7—kidney cancer	9.41e-05	0.00132	CbGpPWpGaD
Gabapentin—Vomiting—Capecitabine—kidney cancer	9.39e-05	0.000103	CcSEcCtD
Gabapentin—Shock—Doxorubicin—kidney cancer	9.36e-05	0.000103	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—kidney cancer	9.33e-05	0.000103	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GSTP1—kidney cancer	9.32e-05	0.0013	CbGpPWpGaD
Gabapentin—Thrombocytopenia—Doxorubicin—kidney cancer	9.32e-05	0.000103	CcSEcCtD
Gabapentin—Rash—Capecitabine—kidney cancer	9.31e-05	0.000103	CcSEcCtD
Gabapentin—Dermatitis—Capecitabine—kidney cancer	9.3e-05	0.000102	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—kidney cancer	9.29e-05	0.000102	CcSEcCtD
Gabapentin—Headache—Capecitabine—kidney cancer	9.25e-05	0.000102	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—kidney cancer	9.24e-05	0.000102	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—kidney cancer	9.2e-05	0.000101	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—kidney cancer	9.07e-05	0.0001	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—kidney cancer	8.89e-05	9.8e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ABCB1—kidney cancer	8.83e-05	0.00123	CbGpPWpGaD
Gabapentin—Nausea—Capecitabine—kidney cancer	8.77e-05	9.66e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ITPR2—kidney cancer	8.75e-05	0.00122	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.67e-05	9.55e-05	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—kidney cancer	8.61e-05	9.48e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GSTM1—kidney cancer	8.57e-05	0.0012	CbGpPWpGaD
Gabapentin—Paraesthesia—Doxorubicin—kidney cancer	8.55e-05	9.42e-05	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—kidney cancer	8.48e-05	9.35e-05	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—kidney cancer	8.46e-05	9.32e-05	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—kidney cancer	8.38e-05	9.23e-05	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—kidney cancer	8.27e-05	9.12e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.22e-05	9.05e-05	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—kidney cancer	8.2e-05	9.04e-05	CcSEcCtD
Gabapentin—Pain—Doxorubicin—kidney cancer	8.14e-05	8.97e-05	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—kidney cancer	8.14e-05	8.97e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP1A1—kidney cancer	8.12e-05	0.00114	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—kidney cancer	7.97e-05	0.00112	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNA1—kidney cancer	7.94e-05	0.00111	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HSPB1—kidney cancer	7.89e-05	0.0011	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EIF4EBP1—kidney cancer	7.89e-05	0.0011	CbGpPWpGaD
Gabapentin—Feeling abnormal—Doxorubicin—kidney cancer	7.84e-05	8.64e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—kidney cancer	7.78e-05	8.57e-05	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—kidney cancer	7.56e-05	8.33e-05	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—kidney cancer	7.52e-05	8.29e-05	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—kidney cancer	7.52e-05	8.29e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PSMD7—kidney cancer	7.33e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ANXA1—kidney cancer	7.33e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TSC1—kidney cancer	7.33e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FLT1—kidney cancer	7.1e-05	0.000994	CbGpPWpGaD
Gabapentin—Hypersensitivity—Doxorubicin—kidney cancer	7.01e-05	7.73e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PTEN—kidney cancer	6.95e-05	0.000973	CbGpPWpGaD
Gabapentin—Asthenia—Doxorubicin—kidney cancer	6.83e-05	7.52e-05	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—kidney cancer	6.73e-05	7.42e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—POMC—kidney cancer	6.7e-05	0.000937	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PAK1—kidney cancer	6.58e-05	0.000921	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUNB—kidney cancer	6.58e-05	0.000921	CbGpPWpGaD
Gabapentin—Diarrhoea—Doxorubicin—kidney cancer	6.51e-05	7.17e-05	CcSEcCtD
Gabapentin—Dizziness—Doxorubicin—kidney cancer	6.29e-05	6.93e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—POMC—kidney cancer	6.08e-05	0.000851	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—POMC—kidney cancer	6.06e-05	0.000847	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—kidney cancer	6.05e-05	6.67e-05	CcSEcCtD
Gabapentin—Rash—Doxorubicin—kidney cancer	6e-05	6.61e-05	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—kidney cancer	5.99e-05	6.61e-05	CcSEcCtD
Gabapentin—Headache—Doxorubicin—kidney cancer	5.96e-05	6.57e-05	CcSEcCtD
Gabapentin—Nausea—Doxorubicin—kidney cancer	5.65e-05	6.23e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—IGF2—kidney cancer	5.38e-05	0.000753	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN2B—kidney cancer	5.36e-05	0.00075	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1R—kidney cancer	5.21e-05	0.000728	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RAF1—kidney cancer	5.02e-05	0.000702	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—kidney cancer	4.95e-05	0.000693	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—kidney cancer	4.9e-05	0.000686	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—kidney cancer	4.83e-05	0.000676	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—kidney cancer	4.5e-05	0.000629	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—kidney cancer	4.29e-05	0.0006	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TSC2—kidney cancer	4.27e-05	0.000598	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTEN—kidney cancer	4.21e-05	0.000589	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—kidney cancer	4.1e-05	0.000573	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KIT—kidney cancer	3.78e-05	0.000528	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APC—kidney cancer	3.78e-05	0.000528	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK3—kidney cancer	3.62e-05	0.000506	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—POMC—kidney cancer	3.59e-05	0.000503	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BRAF—kidney cancer	3.55e-05	0.000497	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK1—kidney cancer	3.44e-05	0.000481	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—kidney cancer	3.29e-05	0.00046	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—kidney cancer	3.25e-05	0.000455	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—kidney cancer	2.99e-05	0.000418	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—kidney cancer	2.97e-05	0.000416	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAF1—kidney cancer	2.96e-05	0.000415	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RELA—kidney cancer	2.95e-05	0.000413	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—kidney cancer	2.93e-05	0.00041	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTOR—kidney cancer	2.89e-05	0.000405	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—kidney cancer	2.71e-05	0.00038	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—kidney cancer	2.66e-05	0.000372	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—kidney cancer	2.59e-05	0.000362	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUN—kidney cancer	2.58e-05	0.000362	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNB1—kidney cancer	2.56e-05	0.000359	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—kidney cancer	2.5e-05	0.00035	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—kidney cancer	2.26e-05	0.000316	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK3—kidney cancer	2.14e-05	0.000299	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—kidney cancer	2.08e-05	0.000291	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK1—kidney cancer	2.03e-05	0.000284	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—kidney cancer	1.92e-05	0.000269	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—kidney cancer	1.76e-05	0.000247	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—kidney cancer	1.71e-05	0.000239	CbGpPWpGaD
